BMAL1 and obesity due to melanocortin 4 receptor deficiency: Treatment of diet-induced obese mice with aREV-ERBagonist decreased obesity by reducing fat mass and markedly improving dyslipidaemia and hyperglycaemia [95], suggesting that inhibition of BMAL1 expression is beneficial for obesity (see above).